pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-451b |
Genomic Coordinates | chr17: 28861371 - 28861438 |
Description | Homo sapiens miR-451b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-451b | ||||||||||||||
Sequence | 7| UAGCAAGAGAACCAUUACCAUU |28 | ||||||||||||||
Evidence | Experimental | ||||||||||||||
Experiments | Illumina | ||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||
SNPs in miRNA |
|
||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ZNF460 | ||||||||||||||||||||
Synonyms | HZF8, ZNF272 | ||||||||||||||||||||
Description | zinc finger protein 460 | ||||||||||||||||||||
Transcript | NM_006635 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ZNF460 | |||||||||||||||||||||
3'UTR of ZNF460 (miRNA target sites are highlighted) |
>ZNF460|NM_006635|3'UTR 1 CAGATGTGGAAAGACTTTTTACGTACACTTCAGTCAACATCCAAGAATTCCTATTAGCGAAATAGTTTTTTAATATAACC 81 ACTGAAGAAAATCTGTGGTGAGAGGAAACATCTTACCATCTGGTCATTCATACTGAAGAGAAACTCCATAAGTATCATCT 161 CTGTGGGAAAACCTGTTTTAGATCATCATTTGTCATCTAAACAATTATGTTAGAAATTGACACAGCCAAGAGTCTTATTC 241 TACATCTGATAATTCACCCATGAAAGAGACCCAGTGGTTACTGTGCACTTAGGAAAACCTTCAGCCACATCTTTCTTATT 321 AGTTTACAGTGAAATGTTATCTCAGGGACATTCAAACAAAGGAGGAGGAGTCATAGGGAAGAGAAAGAAATGGAAGCACA 401 GCTTCTTTCAGACTTCCCTGACAAGCCCATGGCAATTTGTCATCCCCTCCTTATTTTATTTGGGAGAGGGAAATGTTTCA 481 GAAACAAAAGGGCCTCATCCCCTTTATTTTCCCTGTGTATACATTCACTGCTGTCCAGTGCTGTAGACAAACGGTTTGTT 561 TGAAAACATTTTGTGAAAGCCTGCTTTGTTCCACAGCATTGTCTCCACTCTTGAGGAGCAGAAGCATATATCTTTATGAG 641 AAAGATGGAGGCTTGAGTTATGAAATACTTTTACATTTAAGGAGATAAAGGATGTACATATGAATGGGCACATTTTACTG 721 CACACTTCAGACGCTTTGACTTTTTTAAAAAAATTGTTTCTCCGTGTGTCTTTAACCACCCAGTACCATACTTTTTTCTT 801 GATCTGGATCTACTTGTCAATTTCTTCTTTATTTTTCTGTAGGATGGAGATGATATTGTAGCTGTTTGTACATAATGTAA 881 TCCAGGGAGTCCTAATTCTTCCCTCTGATTGTGGTTTCTCAGCTTTTTTACTGCTCTTTAGAGAGAGTAAATAGTTCAAA 961 ATTCACCTCAACAATTTTCTAGAGGTCAATTTGGAACCAAAAATGAAATAAGACATGTAGCTAAAGTAAGTTAAAAGATT 1041 ATGATAAACTCAGAAAATAAACACAGAGAAGGAATCTCATTTTTCAGTCTTACAGAAGATTGTGTGAAGGCTGACTATAC 1121 ATAAAGTGACTGGAATTTTAACAGGTGAACCTGCATATGTATATGCAGGTAGTTGTCACCATGGATTGAGTCCAGTCGTA 1201 GTAATTAATATGTTTAATCAGAATATTTTGGAATTTCTCTTTTGGTATTCTTTTTGTTTCTTTTATTGTTTTTAATTGAC 1281 AATGTTTATGGGGTTTGGTGTGATATTTCAATACATGTGTGCTAAGAGTAATGATCAAATCAGGGTAATTAGCATATCCA 1361 TCTCAATCATTTATCATTTCTTTGTGTTTAGAAACATTCACAGTCTGCTTTTCTAGCTATTTGAAAATATAAAATGTATT 1441 ATTGCCAATTGTACTCATTCTGCAGTGCCACAGAACACTACAACTTATTCAAATGGAATCTTACTTGCTGTAATTTTGTA 1521 TTTGTTAACCAATCTCTATCTGCCTCTCTGCTGTCCTTCCCAGCCTCTGGTTACCACCATTCTCAACCTTTTATGCTTGC 1601 ATATGAGTAGAAACATGGAGTATTTCTCTTTCTGTGTCTAGCTTATTTCACTTAATGTCTTTCAAGCTCATTCATGTTGC 1681 TGTGAATGACAGGTTTATTTTTCATGGCTGAGTAGTATTCCATTGTGTATATATGCCATGTTTTCTTTCTTCATTCATCT 1761 GATAATGGACACTTAGACTGATTTCTTAGCTATTATGAATAGTGCTTCAATAAACATAGGAGTGTAGATCTCTCTTTG Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000360338.3 | 3UTR | UUUUCUUUUAUUUUUAAUCUUGCUGUGAUCUCCUUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
124 hsa-miR-451b Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT060018 | VANGL2 | VANGL planar cell polarity protein 2 | 2 | 4 | ||||||||
MIRT069874 | SRP54 | signal recognition particle 54 | 2 | 2 | ||||||||
MIRT088316 | RAB10 | RAB10, member RAS oncogene family | 2 | 4 | ||||||||
MIRT100747 | VEGFA | vascular endothelial growth factor A | 5 | 12 | ||||||||
MIRT152236 | ZNF460 | zinc finger protein 460 | 2 | 2 | ||||||||
MIRT198492 | USP14 | ubiquitin specific peptidase 14 | 2 | 6 | ||||||||
MIRT204750 | BZW1 | basic leucine zipper and W2 domains 1 | 2 | 12 | ||||||||
MIRT211209 | FGF2 | fibroblast growth factor 2 | 2 | 2 | ||||||||
MIRT234352 | MSL1 | male specific lethal 1 homolog | 2 | 8 | ||||||||
MIRT281810 | MAP2K1 | mitogen-activated protein kinase kinase 1 | 2 | 2 | ||||||||
MIRT369113 | CKMT1A | creatine kinase, mitochondrial 1A | 2 | 2 | ||||||||
MIRT401349 | C5ORF51 | chromosome 5 open reading frame 51 | 2 | 4 | ||||||||
MIRT441509 | ERN1 | endoplasmic reticulum to nucleus signaling 1 | 2 | 2 | ||||||||
MIRT441888 | RD3 | retinal degeneration 3 | 2 | 4 | ||||||||
MIRT443549 | GPR35 | G protein-coupled receptor 35 | 2 | 2 | ||||||||
MIRT444959 | ADAM22 | ADAM metallopeptidase domain 22 | 2 | 2 | ||||||||
MIRT445808 | NFATC2 | nuclear factor of activated T-cells 2 | 2 | 2 | ||||||||
MIRT446509 | ASCC1 | activating signal cointegrator 1 complex subunit 1 | 2 | 2 | ||||||||
MIRT447457 | ST18 | ST18, C2H2C-type zinc finger | 2 | 2 | ||||||||
MIRT448296 | ZDHHC3 | zinc finger DHHC-type containing 3 | 2 | 2 | ||||||||
MIRT463178 | ZNF281 | zinc finger protein 281 | 2 | 2 | ||||||||
MIRT466606 | TBC1D13 | TBC1 domain family member 13 | 2 | 2 | ||||||||
MIRT467235 | SPRED1 | sprouty related EVH1 domain containing 1 | 2 | 2 | ||||||||
MIRT471039 | PISD | phosphatidylserine decarboxylase | 2 | 10 | ||||||||
MIRT471892 | NUAK2 | NUAK family kinase 2 | 2 | 2 | ||||||||
MIRT474151 | LIMA1 | LIM domain and actin binding 1 | 2 | 6 | ||||||||
MIRT474155 | LIFR | LIF receptor alpha | 2 | 2 | ||||||||
MIRT481037 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | 2 | 2 | ||||||||
MIRT483083 | GPR75 | G protein-coupled receptor 75 | 2 | 4 | ||||||||
MIRT485208 | PRKAR2A | protein kinase cAMP-dependent type II regulatory subunit alpha | 2 | 8 | ||||||||
MIRT495187 | ST3GAL1 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | 2 | 2 | ||||||||
MIRT495431 | ATG7 | autophagy related 7 | 2 | 2 | ||||||||
MIRT499160 | FAM83C | family with sequence similarity 83 member C | 2 | 6 | ||||||||
MIRT499505 | GGA3 | golgi associated, gamma adaptin ear containing, ARF binding protein 3 | 2 | 2 | ||||||||
MIRT500400 | ZMAT3 | zinc finger matrin-type 3 | 2 | 10 | ||||||||
MIRT500684 | TRIM37 | tripartite motif containing 37 | 2 | 2 | ||||||||
MIRT501301 | RPS6KB1 | ribosomal protein S6 kinase B1 | 2 | 2 | ||||||||
MIRT504339 | ASGR2 | asialoglycoprotein receptor 2 | 2 | 6 | ||||||||
MIRT505931 | RCAN3 | RCAN family member 3 | 2 | 4 | ||||||||
MIRT513196 | SLU7 | SLU7 homolog, splicing factor | 2 | 2 | ||||||||
MIRT521807 | POM121C | POM121 transmembrane nucleoporin C | 2 | 2 | ||||||||
MIRT522779 | LAMP2 | lysosomal associated membrane protein 2 | 2 | 6 | ||||||||
MIRT530179 | ZBED2 | zinc finger BED-type containing 2 | 2 | 2 | ||||||||
MIRT532397 | SNX3 | sorting nexin 3 | 2 | 2 | ||||||||
MIRT532482 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT532538 | WDR13 | WD repeat domain 13 | 2 | 2 | ||||||||
MIRT534779 | RAN | RAN, member RAS oncogene family | 2 | 2 | ||||||||
MIRT535719 | N4BP1 | NEDD4 binding protein 1 | 2 | 2 | ||||||||
MIRT539310 | AKAP12 | A-kinase anchoring protein 12 | 2 | 4 | ||||||||
MIRT539877 | RPL32 | ribosomal protein L32 | 2 | 2 | ||||||||
MIRT539891 | IRGQ | immunity related GTPase Q | 2 | 2 | ||||||||
MIRT540063 | CEP104 | centrosomal protein 104 | 2 | 2 | ||||||||
MIRT540154 | GTF2B | general transcription factor IIB | 2 | 4 | ||||||||
MIRT540206 | ARHGAP18 | Rho GTPase activating protein 18 | 2 | 2 | ||||||||
MIRT540391 | CRTC1 | CREB regulated transcription coactivator 1 | 2 | 2 | ||||||||
MIRT540595 | ERCC1 | ERCC excision repair 1, endonuclease non-catalytic subunit | 2 | 4 | ||||||||
MIRT540733 | FABP2 | fatty acid binding protein 2 | 2 | 2 | ||||||||
MIRT540949 | SLC25A43 | solute carrier family 25 member 43 | 2 | 2 | ||||||||
MIRT541444 | C18orf32 | chromosome 18 open reading frame 32 | 2 | 4 | ||||||||
MIRT541571 | ZNF43 | zinc finger protein 43 | 2 | 4 | ||||||||
MIRT541601 | ALOX15 | arachidonate 15-lipoxygenase | 2 | 2 | ||||||||
MIRT541933 | ORC1 | origin recognition complex subunit 1 | 2 | 4 | ||||||||
MIRT542394 | WDR12 | WD repeat domain 12 | 2 | 2 | ||||||||
MIRT542414 | SYNJ2BP | synaptojanin 2 binding protein | 2 | 2 | ||||||||
MIRT542481 | APOC3 | apolipoprotein C3 | 2 | 2 | ||||||||
MIRT542621 | XIAP | X-linked inhibitor of apoptosis | 2 | 2 | ||||||||
MIRT542976 | FAM83F | family with sequence similarity 83 member F | 2 | 2 | ||||||||
MIRT543741 | DHCR7 | 7-dehydrocholesterol reductase | 2 | 2 | ||||||||
MIRT544594 | AP5Z1 | adaptor related protein complex 5 zeta 1 subunit | 2 | 4 | ||||||||
MIRT546441 | SNX5 | sorting nexin 5 | 2 | 2 | ||||||||
MIRT548213 | FKBP1A | FK506 binding protein 1A | 2 | 2 | ||||||||
MIRT550471 | OSCAR | osteoclast associated, immunoglobulin-like receptor | 2 | 4 | ||||||||
MIRT555230 | PRKAA1 | protein kinase AMP-activated catalytic subunit alpha 1 | 2 | 4 | ||||||||
MIRT555428 | PPAP2B | phospholipid phosphatase 3 | 2 | 2 | ||||||||
MIRT556368 | MAF | MAF bZIP transcription factor | 2 | 2 | ||||||||
MIRT558149 | ELK4 | ELK4, ETS transcription factor | 2 | 2 | ||||||||
MIRT566181 | PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 2 | 2 | ||||||||
MIRT568468 | ARMC12 | armadillo repeat containing 12 | 2 | 2 | ||||||||
MIRT607594 | TANGO2 | transport and golgi organization 2 homolog | 2 | 2 | ||||||||
MIRT617588 | NDUFB5 | NADH:ubiquinone oxidoreductase subunit B5 | 2 | 2 | ||||||||
MIRT621244 | SIGLEC9 | sialic acid binding Ig like lectin 9 | 2 | 4 | ||||||||
MIRT623679 | HOXD4 | homeobox D4 | 2 | 2 | ||||||||
MIRT625989 | FGFR1OP | FGFR1 oncogene partner | 2 | 4 | ||||||||
MIRT627244 | ZBTB3 | zinc finger and BTB domain containing 3 | 2 | 2 | ||||||||
MIRT632946 | ELOVL6 | ELOVL fatty acid elongase 6 | 2 | 4 | ||||||||
MIRT635872 | SLC11A2 | solute carrier family 11 member 2 | 2 | 2 | ||||||||
MIRT636638 | CHAF1B | chromatin assembly factor 1 subunit B | 2 | 2 | ||||||||
MIRT643563 | WDR73 | WD repeat domain 73 | 2 | 2 | ||||||||
MIRT647907 | CIRH1A | UTP4, small subunit processome component | 2 | 2 | ||||||||
MIRT652503 | TMEM170A | transmembrane protein 170A | 2 | 2 | ||||||||
MIRT652843 | TACO1 | translational activator of cytochrome c oxidase I | 2 | 2 | ||||||||
MIRT653299 | SMUG1 | single-strand-selective monofunctional uracil-DNA glycosylase 1 | 2 | 2 | ||||||||
MIRT659383 | CREG2 | cellular repressor of E1A stimulated genes 2 | 2 | 2 | ||||||||
MIRT661339 | TBC1D15 | TBC1 domain family member 15 | 2 | 2 | ||||||||
MIRT662372 | ANKRD42 | ankyrin repeat domain 42 | 2 | 2 | ||||||||
MIRT664322 | CD209 | CD209 molecule | 2 | 2 | ||||||||
MIRT671759 | F11R | F11 receptor | 2 | 2 | ||||||||
MIRT673240 | KLHDC8A | kelch domain containing 8A | 2 | 2 | ||||||||
MIRT682871 | C9orf156 | tRNA methyltransferase O | 2 | 2 | ||||||||
MIRT683171 | SF3A1 | splicing factor 3a subunit 1 | 2 | 2 | ||||||||
MIRT684262 | TBXA2R | thromboxane A2 receptor | 2 | 2 | ||||||||
MIRT684395 | MCTS1 | MCTS1, re-initiation and release factor | 2 | 2 | ||||||||
MIRT684883 | P4HB | prolyl 4-hydroxylase subunit beta | 2 | 2 | ||||||||
MIRT686650 | TMEM184C | transmembrane protein 184C | 2 | 2 | ||||||||
MIRT687771 | KIAA0355 | KIAA0355 | 2 | 2 | ||||||||
MIRT694352 | CHST6 | carbohydrate sulfotransferase 6 | 2 | 2 | ||||||||
MIRT696347 | SLC35D2 | solute carrier family 35 member D2 | 2 | 2 | ||||||||
MIRT700480 | PUM1 | pumilio RNA binding family member 1 | 2 | 2 | ||||||||
MIRT705909 | ADAM9 | ADAM metallopeptidase domain 9 | 2 | 2 | ||||||||
MIRT714076 | FNDC3B | fibronectin type III domain containing 3B | 2 | 2 | ||||||||
MIRT714401 | FBXO31 | F-box protein 31 | 2 | 2 | ||||||||
MIRT716442 | RPS24 | ribosomal protein S24 | 2 | 2 | ||||||||
MIRT718204 | PSMF1 | proteasome inhibitor subunit 1 | 2 | 2 | ||||||||
MIRT721238 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT721271 | SH3D19 | SH3 domain containing 19 | 2 | 2 | ||||||||
MIRT721603 | ZNF484 | zinc finger protein 484 | 2 | 2 | ||||||||
MIRT722916 | COA4 | cytochrome c oxidase assembly factor 4 homolog | 2 | 2 | ||||||||
MIRT723457 | CUL4A | cullin 4A | 2 | 2 | ||||||||
MIRT733813 | KREMEN1 | kringle containing transmembrane protein 1 | 2 | 0 | ||||||||
MIRT733814 | CASK | calcium/calmodulin dependent serine protein kinase | 2 | 0 | ||||||||
MIRT733815 | KLF4 | Kruppel like factor 4 | 2 | 0 | ||||||||
MIRT733816 | BCL2 | BCL2, apoptosis regulator | 2 | 0 | ||||||||
MIRT733817 | PCNA | proliferating cell nuclear antigen | 2 | 0 | ||||||||
MIRT733818 | BAX | BCL2 associated X, apoptosis regulator | 2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|